Market Research Blog

Global low fat product market is estimated to notice rapid growth over the forecast period.  The factor that attributes to rise the low fat product market is growing health awareness among the population around the world. Increasing problem of obesity, cardiovascular diseases and diabetes over the years have triggered the demand for low fat products and it is expected to fuel the market for low fat products. In developing countries such as India, China, Mexico and Brazil, changing lifestyle of consumers and rapid urbanization is anticipated to be a key driver for low fat products.

Increasing retail sector and increasing disposable income of consumer is expected to have favorable impact on low fat product market. Introduction of dietary supplements, low fat cereal bars and functional foods over past few years has increased the demand for low fat products because of the lack of physical activity and hectic and busy lifestyle. Additionally, making investment in research and development is fostering product innovation in the low fat product market. The constant R&D activities are contributing growth in the global market of low fat products.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13052

Low fat products consist of healthy cereals, low fat dairy products, low fat drinks and snacks. Advancement in technology and increasing automation process in the industry are estimated to boost the low fat product industry growth. Changing preference of consumer across the globe regarding the intake of healthy, tasty and organic foods are predicted to propel the demand of low fat product market. Growing consumption and production of organic products in the European market is estimated to boost the low fat product industry.

Many companies are innovating their products due to increasing popularity of new and organic product in the market. The production of low fat products is mainly driven by the West Europe and the United State companies. The key player of this region such as Danone and Nestle are expanding their manufacturing units across the globe to make their products easily available to everyone.

Increasing Health Awareness and Changing Consumer Preference is Driving the Low Fat Market

Rising awareness about the health associated benefits from fat free products around the world is estimated to boost the demand for low fat products across the world. People are becoming more health conscious and they are choosing healthy diet over other foods to maintain a healthy lifestyle. Increasing number of obese population which is moving towards healthy lifestyle is making a positive impact on global low fat products.

Moreover, changing lifestyle is very common now a day, hectic and busy life compel the consumers to go for healthy foods which are low in fat and low in calories. Mostly, consumers are aware about the risk associated with their health with the consumption of high fat food and high calorie contain foods, thus it promote the market to increase the demand for products which promotes physical health with nutritional values by consuming low calorie and low fat products.

Increasing investment in research which in turn helps in product development and new products are launched to satisfy consumer’s needs. For instance, there is a lot of development happened in low fat dairy products such as introduction of low fat yogurt. In 2019, Danone had launched two yogurt lines that tap both low sugar and plant based trend. The first is Greek low fat yogurt which is a dairy base product which include low sugar and low calorie. The second is Good plants it is a dairy free probiotic yogurt made with almond milk. Development and expansion of product portfolio boost the global low fat product.

Development in retail infrastructure drives the consumption of low fat products. Supermarket/hypermarket making is easy availability of products for consumer which is fueling the growth of global low fat products. Since the ingredients used in low fat products are costlier, hence the price of the product becomes costlier in comparison with other foods. This is one of the key restraints of the low fat products globally.

Low Fat Products: key Players

Some of the key players operating in global fat free product are as follows-

• kelloges
• Amul
• Ajinomoto company Inc.
• Cargill, PepsiCo
• Danone
• Nestle
• Arla food amba
• Fonterra
• Bernard food industry

and many more. Many manufacturers of low fat products are moving towards product innovation by introducing new product variants in the existing product line, or by acquiring other companies which are already in the same market or they are expanding their geographical boundries by opening their new plant.

• For instance, in 2020 Tillamook launched a new yogurt in low fat yogurt product line. Oregon a United State company launched yogurt in six different flavors with no flavor, sweetener and preservatives. Each cup includes two side by side flavors which can be enjoyed one by one or by swirled together.
• In 2018, Arla food launched Arla fiber, a new range of yogurt which is rich in fibers. It is available in four different flavors. Its every serving contains 4.7 grams of fibers, its low in fat and high in protein and contain 27% of daily calcium.
• Breyers launched four new flavors of ice creams chocolate, vanilla, cookies & cream and mint chip. It clearly communicates on the front of the pack highlighting high protein and low sugar.
• In 2018, Cargill food launched low fat edible oil in India, revamping its Nature Fresh acti-lite array by positioning it as low fat cooking oil at affordable price.

Low Fat Products Market: Regional Analysis

North America dominates the market by holding the market share followed by Europe. Over the year the manufacture of low fat products has been globalized due to the growth of economic in developing nations. The demand of low fat product is driven by the key manufacturersavailable in western European regions. The market of North America is driven by increasing intake of low fat dairy products in United State. A huge number of local players are present in United State and these manufacturers are trying to launch new variants or flavors in the product to rise their market share.

Asia pacific is growing as a budding market with increase in rate of consumption of low fat products in regions such as India, China and Japan. Changing preference of consumer and rising number of consumer choosing organic products is estimated to propel the demand of low fat product in the market. Australia and New Zeeland are the key suppliers of processed milk in the region. The increasing export of dairy products from this country is predicted to boost the low fat product market during forecast period.

The research report presents a comprehensive assessment of the low fat product market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as application, product type, form, nature and sales channel.

The report covers exhaustive analysis on:

• low fat product market Segments
• low fat product market Dynamics
• low fat product candy market Size
• low fat product Supply and Demand
• Current Trends/Issues/Challenges pertaining to low fat product market
• Competition Landscape and Emerging Market Participants inlow fat product market
• Technology related to Production/Processing of low fat product.
• Value Chain Analysis of the low fat product

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
• East Asia (China, Japan, South Korea)
• South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
• Oceania (Australia, New Zealand)
• Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

NOTE: All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Low Fat Products: Market segmentation

On the basis of Source:

• Conventional
• Organic

On the basis of Type:

• Low fat dairy products
  • Ice cream
  • Yogurt
  • Skim milk
  • others
• Low fat cereals products
• Low fat drinks
• Low fat snacks products
• Others

On the basis of Distribution Channel:

• Hypermarket/supermarket
• Convenience store
• Specialty store
• Online retail
• Others

Pre-Book This Report@ https://www.futuremarketinsights.com/checkout/13052

Report Highlights:

• Detailed overview of parent market
• Changing dynamics of the low fat product market in the industry
• In-depth market segmentation and analysis
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments in low fat product market
• Competitive landscape of the low fat product market.
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective low fat product market performance
• Must-have information for low fat product market players to sustain and enhance their market footprint.

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Polydextrose is a low calorie, low glycemic and sugar free carbohydrate that has varieties of functional properties which includes high water solubility, prebiotic properties, and decreases total cholesterol levels in blood serum; these functional benefits have led to considerable interest from food industry to use polydextrose in development of new healthy products.

With the increase in competition among companies producing functional ingredients as the food and beverage industry is flourishing globally, companies are in the process of continuous research and development to design novel products to remain prominent in the market. However, as the competition is high, wide varieties of sweeteners and dietary fibers are available.

But with unique formulations and utilization of polydextrose as a part of functional ingredient system incorporating a blend of various sweeteners, emulsifiers, and stabilizers etc. is expected to maintain the demand of polydextrose over forecasted period.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13020

Polydextrose Ingredients: Market Drivers

Due to growing demand in functional foods because of the prebiotic properties is projected to propel the market growth. Polydextrose low sugar content property is often used to produce diabetic foods and sugar free products. Change in consumer’s preferences towards health consciousness is expected to fuel the market over forecasted period.

Recently, the trend of using clean label products is increasing among the consumers. Manufacturers of food and beverage industry are preparing products using polydextrose and labeling the products as reduced sugar, low calorie, reduced fats as per the target consumers.

Food and Drug Associations favorable regulations are anticipating the growth of polydextrose ingredient market in North America. Due to continuous demand of low calorie, and reduced fat food from developing countries is driving the growth in Asia Pacific region which includes India, Japan, China and Australia.

Global Polydextrose Ingredients Market: Key Players

Some of the key players manufacturing banquet carts and heated cabinets are as follows – product innovation includes STA-LITE which is a polydextrose product produced by Tate and Lyle are applied on different products such as yogurt, cereal bars, and ice creams. Some of the global key participants in the industry include

• Tate and Lyle
• Danisco A/S
• Medallion Labs
• Baolingbao Biology
• MengzhouTalijie
• Vitahealth
• CJ CheilJedang
• Shandong Minqiang Biotechnology Company Limited
• Cargill Inc.
• Samyang Genex
• Others.

Opportunities for Global Polydextrose Ingredients Market Participants:

With increasing number of diabetic population in Asia Pacific Region of the globe and moreover, due to consumer’s demand for low calorie food are anticipated to trigger the growth of polydextrose market. However, the changing eating pattern is a major macroeconomic phenomenon for the growth. With North America, Europe is also anticipated to capture a significant market share for global polydextrose ingredients market, due to increasing health issues among the population.

The Global Polydextrose Ingredient Market report offers a complete assessment of the market. It does so by doing detailed assessment of historical data, qualitative insights and verifiable projections about market size. Proven research methodologies and assumptions are been used to derive projections which are featured in the report. The research report serves as a repository of analysis for every facet of Global Polydextrose Ingredients Market, including: regional markets, end use type and form type.

The Report Covers Exhaustive Analysis on:

• Polydextrose ingredient market segment
• Polydextrose ingredient market dynamics
• Polydextrose ingredient market size
• Polydextrose ingredient supply and demand
• Current trends/issues/challenges pertaining to polydextrose ingredient market
• Competition landscape and emerging market participants in polydextrose ingredient market
• Technology related to production/processing of banquet carts and heated cabinets
• Value chain analysis of the Polydextrose ingredient market

Regional Analysis Includes:

• North America (U.S., Canada)
• Latin America (Mexico, Brazil, Rest of Latin America)
• Europe (Germany, U.K., France, Italy, Spain, BENELUX, Poland, Russia, Nordic, Rest of Europe)
• East Asia (China, Japan, South Korea)
• South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
• Oceania (Australia, New Zealand)
• Middle East & Africa (GCC Countries, South Africa, Rest of MEA)

The polydextrose ingredient market report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analysing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the Polydextrose ingredient market report projects the attractiveness of each major segment over the forecast period.

Polydextrose Ingredients: Market Segmentation

Based on Ingredient :

• Sorbitol
• Citric Acid

Based on Form :

• Powder
• Liquid

Based on End Use :

• Bakery & Confectionery
• Breakfast Cereals
• Snacks & Bars
• Dairy Products
• Desserts & Ice Cream
• Soups, Sauces, & Dressings
• Spreads & Fillings
• Beverages & Dairy Drinks
• Dietary Supplements
• Animal Feed and Pet Food

Pre-Book This Report@ https://www.futuremarketinsights.com/checkout/13020

Highlights of the Polydextrose Ingredient Market Report:

• A complete backdrop analysis, which includes an assessment of the parent market
• Important changes in market dynamics
• Market segmentation up to the second or third level
• Historical, current, and projected size of the market from the standpoint of both value and volume
• Reporting and evaluation of recent industry developments
• Market shares and strategies of key players
• Emerging niche segments and regional markets
• An objective assessment of the trajectory of the polydextrose ingredient market
• Recommendations to companies for strengthening their foothold in the polydextrose ingredient market

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Natural flavors are organic-based raw materials often used in the processing of food. They act as ingredients to enhance the taste of food products. For a substance to be listed as a natural flavor, it must be obtained from either plant or animal source; therefore, it must be organic. Natural flavors are usually derived from ingredients such as meat, seafood, eggs, dairy products, poultry, vegetable, fruits, bark, bud, root, and other organic sources through distillation or fermentation. These ingredients function is to add flavor rather than nutrients to foods.

The rise in demand for natural ingredients, increasing health concern, disregard towards the consumption of chemical or artificial food products are factors fueling the growth of the global natural flavors market in the food and beverage industry.

Request for the Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-598

Natural Flavors Market Growth Driven by Consumers’ Growing Demand for Natural Products

With the rise in awareness regarding the adverse effect of consuming artificial or synthetic ingredients, the natural flavors market should expect a tremendous growth over the forecast period. Consumers are conscious about their health and are willing to spend on healthy food products.

Also, the rise in demand for clean label products is another factor to watch out for as it is projected to boost the market significantly during the forecast period and aftermath

Growing Disposable Income

The rise in disposable income and the high population size of consumers is a strong force fueling the growth of the natural flavor market globally. Developing nations like India, China, and Japan are currently witnessing an upsurge in their economies, and this has facilitated the rise in the disposable income of individuals within the nations.

Food and Beverage Industry in Steady Demand for Natural Flavor

The food and beverage industry finds natural flavors as an essential product essential for the enhancement of taste and quality of foods and beverages produced from the industry. Natural flavors are a composition of a variety of organic compounds that are volatile in nature capable of enhancing the taste and quality of food. The rise in consumer demand for natural ingredients is a crucial factor in fueling the growth of the industry.

Natural Flavors Market Restraint

The global natural flavors market is not without its challenges. Some of the forces expected to impact the market negatively include the high cost of production and instability of natural flavor. The cost of obtaining the raw materials required for the production of natural flavors is threatening the growth of the natural flavors market globally. Consumers might be forced to shun the natural flavors market owing to the high cost of natural products.

Natural Flavor Market: Region-wise Analysis

Europe remains the largest market for the natural flavor market, with the United Kingdom acting as a driver. The region will remain in dominance even after the forecast period owing to the rise in demand for organic ingredients within the UK and other European countries like Germany and France.

The Asia Pacific region will record a double-digit CAGR over the forecast period. And this is due to the rise in demand for natural flavor in countries like China, India, and others. With the increase in demand for organic products, North America is projected to witness significant growth within the forecast period.

Natural Flavor Market: Competitive Landscape

The natural flavor market is highly consolidated. Some of the key characteristics of the market are the introduction of clean label and organic flavor ranges, and the merging of major players with local players to extend market to places where there is little or no recognition.Some of the major players in the global natural flavor market are:

• Kerry Group
• Givaudan
• Firmenich
• Sensient Technologies Corporation
• Symrise AG

Frutarom Industries to understand their influence on the overall market. Other key players listed in the report are

• Hasegawa Co.
• International Flavors & Fragrance Inc.
• Wild Flavors Inc
• Huabao International
• Takasago International Corp

Region-wise Analysis

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
• East Asia (China, Japan, South Korea)
• South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
• Oceania (Australia, New Zealand)
• Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

Request for the complete TOC of this report: https://www.futuremarketinsights.com/toc/rep-gb-598

Report Highlights

The research report presents a comprehensive assessment of market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data and projections with suitable set of assumptions and methodology. Research report provides analysis and information by categories such as market segments, geographies, types, technology and applications.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts, and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Global Natural Flavor Market Segment Analysis

The global natural flavor market can be segmented on the following basis:

By Type

• Natural Flavor
• Synthetic Flavor
• Natural Identical Flavoring

By Application

• Dairy
• Bakery
• Snack
• Confectionery
• Beverage
• Others

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

 

 

According to the latest research by Future Market Insights, Rapid Hepatitis Testing Market is expected to witness robust growth with 4-5% CAGR during the forecast period from 2021 to 2031. The rising prevalence of hepatitis caused due to liver infection and an increasing focus on molecular diagnostics is likely fuelling the global rapid hepatitis testing market growth. Therefore, growth at a significantly high CAGR will be expected soon. 

What is Driving the Demand for Rapid Hepatitis Testing?

The availability of advanced diagnostic procedures for hepatitis tastings expects to boost the market growth in the coming years. The paradigm shift of the researchers and manufacturers to molecular diagnostics from conventional technologies has amplified the capability of procedures that has minimized the testing time.

For example, molecular diagnostics detect the presence of a virus that is involved by performing genetic tests to confirm the exact strain of the causative virus. Furthermore, the rising prevalence of hepatitis among the growing population is also expected to fuel market growth.

According to World Health Organization (WHO), around 325 million people are living with hepatitis B and/or C, and for most globally. To reduce the current global burden of hepatitis, the key players have increased focus on research area efforts to develop an effective rapid test that enables virus identification and eases linkage to various healthcare setting. For instance, in February 2019, Abbott has received CE Mark for the Determine™ HBsAg 2 test, the most sensitive rapid diagnostic test used for hepatitis B surface antigen detection.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13367

COVID-19 Impact on Rapid Hepatitis Testing Market Growth

The COVID-19 pandemic projected a significant impact on the rapid hepatitis testing market. Countrywide lockdown, disruption in supply chain and halt on transportation subjected product shortage. Global demand for vaccination led the manufacturers to focus on the vaccine production that has likely decreased the production of the other products that has no emergency headed significant impact on the rapid hepatitis testing market growth.

The U.S. and Canada Rapid Hepatitis Testing Market Outlook

U.S. and Canada will hold the top position in the rapid hepatitis testing market due to the rising prevalence of viral infection, the number of hepatitis cases caused due to change in lifestyle, and high consumption of alcohol, drug or toxins in the American countries. According to the Centre OF Disease and Control (CDC) total 18,846 of hepatitis A, a total of 3,192 acute hepatitis B, and around 4,136 acute hepatitis C cases were reported in 2019.

Europe Demand Outlook for Rapid Hepatitis Testing

Europe holds the second-most position in the rapid hepatitis testing market due to the growing number of hepatitis cases in the European countries. According to WHO European Region, in 2019, around 15 million people living with hepatitis B a­ffects lives of infection. Central Europe has the high per cent of cases around 6-8% of people living with Hepatitis B, while western, northern and central European countries has less than 0.1% of cases.

Who are the Key Players of Rapid Hepatitis Testing Market?

Some of the leading players in the rapid hepatitis testing market include

• Abbott Laboratories
• Siemens Healthcare GmbH
• Bio-Rad Laboratories, Inc.
• Bayer AG
• CTK Biotech, Inc.
• QIAGEN
• Thermo Fisher Scientific Inc.
• BioGenex
• Biochrome Scientific
• Others

These companies followed certain strategies like a partnership, new product lunch and approval, merger and acquisitions to gain a good position in the market. For instance, in May 2021, Biosynex SA acquired Avalun SAS, a company developing the Labpad in vitro diagnostic device providing rapid biological test results from small sample volumes.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13367

Rapid Hepatitis Testing Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Key Segments

By Test Type:

• Serologic Antibody Assays

  • Enzyme Immunoassay (EIA)
  • Chemiluminescence Immunoassay (CIA)
  • Point-of-Care Rapid Immunoassays
  • Recombinant Immunoblot Assay (RIBA)
• Molecular HCV RNA Tests
  • Qualitative HCV RNA
  • Quantitative HCV RNA
• Immunoassays For HCV Core Antigen

By Indication:

• Hepatitis A
• Hepatitis B
• Hepatitis C

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online pharmacies

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13367

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

According to the latest research by Future Market Insights, At-Home Cancer Testing Market is expected to witness robust growth with 4-5% CAGR during the forecast period from 2021 to 2031. The At-Home Cancer Testing will show growth due to the rising prevalence of cancer globally and an increase in investment to develop at-home cancer testing kits. Therefore, growth at a significantly high CAGR will be expected soon. 

What is driving the Demand for At-Home Cancer Testing?

The rising geriatric population and cancer prevalence is driving the at-home cancer screening market. Increasing adoption of at-home screening is anticipated to grow the at-home devices for cancer screening. According to the North American Association of Central Cancer in 2020, 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States.

Pre-detection of cancer for prevention and early treatment is leading the market in the forecasted period. At-home testing for colon cancer is anticipated to fuel the market in the forecasted period. It is recommended to have a colorectal diagnosis after 50 years of age.

Also, with increasing demand in the field of diagnosis, the major players and different countries made advances in their research and technology for making the process easy, painless, and rapid. All these factors drive the At-Home Cancer Testing Market significantly during the forecast period from 2021 to 2031.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13365

COVID-19 Likely to Propel the Growth of At-Home Cancer Testing Market

With the outbreak of COVID-19, the world started following social distancing. Social distancing is the most important factor for dropping the cases of COVID-19 and breaking the chain of the virus. Long overshadowed by colonoscopy, stool-based screening tests that patients perform at home are getting a boost as hospitals halted and then curtailed nonemergency procedures to preserve resources and prevent novel coronavirus transmission.

Few market players have launched testing kits to test for colon cancer at home. There has been a drop-off in the physician visiting which has given rise to the need to perform the test at home. Patients don’t need to visit the hospital, diagnostic centre, or clinic for cancer testing.

The U.S. and Canada At-Home Cancer Testing Market Outlook

U.S. and Canada will retain the top position in the market of at-home cancer testing due to the rising prevalence of cancer in the region and increasing adoption of home testing kits.

Colorectal cancer is the second most common cause of cancer death in the United States. According to the American Cancer Society in the U.S. in 2020, 104,610 new cases of colon cancer were detected and 43,340 cases of rectal cancer diagnosed in the US.  More than 3000 deaths have been recorded in 2020 due to colorectal cancer.

This rate is higher in patients with age more than 50 years. The high geriatric population will accelerate the at-home cancer testing market. However, some populations need to make aware of the at-home cancer testing availability for early diagnosis. Thus need for home cancer testing is increased significantly.

Europe Demand Outlook for At-Home Cancer Testing

Europe was hit badly by the corvid-19 pandemic in 2020. This makes them focus primarily on their healthcare sector and developing new technologies and adopting new devices for minimizing the discomfort of the population.

According to European Cancer Information System in 2020, 341,419 new cases were recorded with 156,105 deaths. Deaths have been found higher in aged people. The deaths can only be controlled by early diagnosis and treatment.

Therefore, it is important to adopt such methods as At-Home Cancer Testing and self-testing kits to follow the social distancing and avoid gathering of people at hospitals, clinics, and diagnostic labs. This will result in developing the At-Home Cancer Testing demand in Europe during the forecast period.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13365

Who are the Key Manufacturers and Suppliers of At-Home Cancer Testing?

Some of the leading manufacturers and suppliers of At-Home Cancer Testing include

• ELITech Group SAS
• Everlywell, Inc.
• Exact Sciences Corp.
• Laboratory Corporation of America Holdings
• Lepu Medical Technology Co., Ltd.
• GY Highland Biotech LLC
• ulti med Products GmbH
• Abingdon Health Quidel Corporation
• Others

These companies followed certain strategies like a partnership, new product launch and approval, mergers and acquisitions to gain a good position in the market.  For instance, in August 2018, Exact Sciences and Pfizer announced an agreement through 2021 to co-promote Cologuard.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

At-Home Blood Collection System Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Key Segments

By Cancer Type:

• Colon
• Breast
• Prostate
• Blood
• Bladder

By Sample:

• Blood
• Urine
• Cell
• Stool

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online pharmacies
• Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13365

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

According to the latest research by the Future Market Insight, The Non-Invasive Respiratory Monitoring market is set to witness a Soaring growth in the forecast period 2021-2031 at a CCAGR of 8%. Respiratory monitoring device has wide range of application in all diseases related to respiration. 

In the developing world the air is getting polluted at a high rate due to this may breathing problems occurs to the citizens worldwide. In fact, respiratory diseases are listed in the world’s biggest health concerns, causing one-sixth of all deaths globally. These reasons signifies the soaring growth of the market in forecast period globally .

What is Driving Demand for Respiratory Monitoring Market?

The growing rate of respiratory disease globally due to the developments going on worldwide drives the market demand in the coming period. Factors such as highly accurate, rapid, and effective results produced by the Respiratory monitoring devices fuel the growth of the market.

The Increasing prevalence of asthma and chronic obstructive pulmonary diseases (COPDs) are some of the major factors driving the demand for respiratory monitoring devices.

The Covid-19 pandemic became the major factor responsible for the bullish growth in the market. Increasing efforts to introduce new technologies, sensors which are capable of providing accurate measurement on respiration rate.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13364

COVID-19 Pandemic Likely to Augment Demand of Non-Invasive Respiratory Monitoring Market.

Covid-19 pandemic had a disastrous effect on citizens worldwide. The pandemic had a direct impact on the respiratory system of humans, In this period of covid-19  pandemic the manufacturers introduced new technology called pulse oximeter, which gives the accurate result for pulse rate and oxygen level in blood with the help of sensors, hence the covid-19 pandemic had a positive impact on the market as the demand for the respiratory monitoring devices increased at a high rate which helped in booming the market.

U.S. and Canada Non-Invasive Respiratory Monitoring Market Outlook

North American region holds the largest share in the respiratory monitoring devices. The factor responsible for the large share in segment are, the high awareness about Oximeters, spirometers and plethysmographs, economic capability to purchase expensive machines in large number, prevalence of respiratory diseases, rising demand for technologically advanced and innovative products in hospitals, diagnostic laboratories, home care , and outpatient ambulatory surgery centers and presence of well established companies in the region.

Europe & Asia pacific Demand & Outlook for Non-Invasive Respiratory Monitoring Market.

Europe holds the second largest share in the market, the factors responsible for the same are, the Highest Covid-19 cases which led in the highest demand of the respiratory monitoring market, The presence of established companies and developing companies boosts the demand of market.

Asia pacific is predicted to be the fastest developing region as the heath care expenditure is increasing year on year, the population is increasing, number of emerging companies is increasing every year, the introduction of new technologies boosts the demand of the market.

Who are the Key Manufacturers and Suppliers of Non-Invasive Respiratory Monitoring Products?

According to FMI Analysis,

• VYAIRE (CareFusion Corporation)
• Smith & nephew
• GENERAL ELECTRIC
• ResMed
• Masimo
• COSMED srl
• MGC Diagnostics Corporation
• Koninklijke Philips N.V.
• Medtronic, and Teleflex Incorporated
• Nihon Kohden Corporation
• Novelda AS
• Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)

are identified as the key players of the Non-invasive respiratory monitoring market.

Masimo Corporation introduces Root Patient monitoring and connectivity platform in September 2020.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13364

Non-Invasive Respiratory Monitoring Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Key Segments

By Product:

• Spirometer
• pulse oximeter
• peak flow meter
• capnographs

By End Users:

• Hospitals
• Clinics
• Home care

By Region:

• Oceania
• South Asia
• East Asia
• Europe
• Latin America
• North America
• Middle East and Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13364

According to the latest research by FMI, submucosal injections market is set to witness a 7.3% growth during the year 2021-2031. The global demand for submucosal injections is expected to grow at a moderate pace during the forecast period. The submucosal injections are required principally during the endoscopic mucosal resection techniques.

They are an indispensable part of endoscopic submucosal dissection. Thus the submucosal injections are expected to grow in value by commonly being used in the treatment of diseases such as cancers (esophageal, small intestine and gastric), polyps in the colon and Barrett’s esophagus. The most common submucosal agents are dextrose water, hydroxypropyl methylcellulose, normal saline, hyaluronic acid, hydroxyethyl starch and Orise gel.

What is Driving Demand for Submucosal Injections?

Submucosal injections are an indispensable part of endoscopic submucosal dissection. Thus the submucosal injections are expected to grow in value by commonly being used in the treatment of diseases such as cancers (esophageal, small intestine and gastric), polyps in the colon and Barrett’s esophagus.

The use of these injections thus accounts for the minimization of adverse effects and untangles polypectomy. The rise in the application of submucosal injections is attributed to the increasing cases of several cancer types and their use in surgeries for the helpful removal of cancer cells before their growth. The factor of this technique being less invasive allows greater adoption of submucosal injections.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13375

Which Factors are Likely to Augment Growth of Submucosal Injection Adoption?

The augmentative factors which are expected to propel the development of submucosal injections are the increasing demand for endoscopic procedures, especially in the developed economies. Additionally, the rise in the number of patients with the intention of seeking treatment for early stage stomach cancer or premature cancer has also assisted with the increased growth and demand for submucosal injections.

Also, the introduction of new submucosal lifting agents such as, the development of Eleview by Cosmo Pharmaceuticals N.V., which is a ready-to-use and safe submucosal lifting agent, has led to advanced research and adoption of submucosal injections.

US and Canada Submucosal Injections Outlook

The submucosal injections value is likely to experience a lucrative growth in the region of North America. The countries US and Canada amount to the largest share in the submucosal injections application. According to the US National Cancer Institute, cancer incidence rate is 442.4 per 100,0000 men and women per year.

The increasing cases of several cancer types which include gastro, esophageal and colorectal cancers in these countries has accounted for the increase in demand of submucosal injections. Additionally, the demand is also gaining traction because of advanced healthcare infrastructure as well as favorable reimbursement policies in North America.

Europe Demand Outlook for Submucosal injections

The Europe submucosal injections sales is set to gain significant traction due to the increasing healthcare expenditure. The incidence rate of primarily esophageal cancer in the U.K. and Netherlands is highly standardized. The advancement of technology in terms of treatment of early stomach cancer, intestinal cancer and esophageal cancer is set to advance the European submucosal injections growth.

Who are the Key Manufacturers and Suppliers of Submucosal injections?

The key manufacturers of the submucosal injections are

• Bio Space Inc.
• GI Supply Cosmo Pharmaceuticals N.V.
• FUJIFILM Medical Systems
• Medtronic Plc.
• Zeon Medical
• Boston Scientific
• Aries Pharmaceuticals
• Sumitomo Bakelite Co.
• ERBE Elektromedizin GmbH
• Ovesco Endoscopy AG

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13375

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

According to the latest research by FMI, pre-filled hemostasis agents market is set to witness a 6.8 % growth during the year 2021-2031. Hemostasis is a major challenge, primarily in surgical procedures and trauma. Hemostasis agents are primarily in the form of fibrinogen concentrate, dried plasma, dried and synthetic platelets, tranexamic acid and topical hemostatic products.

The use of pre-filled hemostatic agents in pre-hospital trauma through combat or in civilian settings has led to a reduction in preventable deaths due to hemorrhage. This is one of the prime factors driving the growth and demand. Apart from this, the pre-filled hemostatic agents are ready to use and do not require on-site mixing or pre-application preparation.

The property of biocompatibility and low cost and ease of use of these agents have resulted in increased adoption in combat fields as well as a gradual adoption in pre-hospital trauma. These factors are expected to improve the product adoption, as well as demand during the forecast period.

What is Driving Demand for Pre-filled Hemostasis Agents?

The key factors which drive the demand for the pre-filled hemostasis agents are the increasing number of surgical procedures like orthopedic procedures with respect to hip and knee replacement and hernia operations. Apart from these, the rise in the number of geriatric population and the prevalence of wounds and injuries associated with that have led to increased adoption of pre-filled hemostasis agents. The use of hemostasis agents in the field of cardiovascular surgery procedures for the efficient management of bleeding has also effectuated the application of the pre-filled hemostasis agents.

Which Factors are Likely to Augment Growth of Pre-filled Hemostasis Agents?

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13374

The advancement in technology in reference to the hemostatic agents and their applications in the field of medicine has aided patients with emergency assistance to prevent hemorrhage. The increasing growth of chronic diseases and injuries, high risk associated with heart diseases and birth defects and research apropos of disorders such as hemophilia also increase value of pre-filled hemostasis agents.

Global prevalence of diabetes is expected to reach 366 million by 2030 with current prevalence as 26.9% of population with age group of 65 and over and about 60% have cancer. Overall of 8-18% patients with cancer suffer from diabetes. This correlation is effectively justifiable in cases of diabetes induced cardiovascular risk. Hemostatic agents are thus effective during potential bleeding complications and hence expected to augment to the demand surge over the forecast period.

US and Canada Pre-Filled Hemostasis Agents Outlook

The US dominates the global pre-filled hemostasis agents in terms of value. The growth is attributed to the increasing demand of surgical procedures in the North America region. In 2018, a record of about 210,454 people over the world suffered from hemophilia and out of those, about 18,008 people belonged to the US. The rising prevalence of bleeding disorders in North America has led to the adoption of hemostasis agents for bleeding management. Apart from this, the rising geriatric population in both US and Canada has attributed to wound and injury, as well as the advent of chronic diseases such as heart disorders and diabetes.

Europe Demand Outlook for Pre-filled Hemostasis Agents

The Europe pre-filled hemostasis agents application is experiencing an increase in the previously dormant initiation of the use of hemostasis agents during post-partum hemorrhage. According to the German Post-Partum Hemorrhage guidelines, the procedures for controlled bleeding management includes the use of pre-filled hemostasis agents, especially with patients suffering from hemophilia or von Willebrand disease. Germany thus holds a key share in the Europe pre-filled hemostasis agent application.

Who are the Key Manufacturers and Suppliers of Pre-filled Hemostasis Agents?

The key manufacturers in the pre-filled hemostasis agents production and sales are

• Baxter International Inc.
• Pfizer Inc.
• Advance Medical Solutions Group
• Integra Life Sciences Corporation
• CryoLife, Inc.
• Medtronic Plc
• Equimedical
• Vascular Solutions, Inc.
• C.R. Bard Incorporation
• Z-Medica Corporation
• Nihon Kohden
• Sanyo Chemical Industries, Ltd.
• hangzhou singclean medical products co. ltd
• Johnson and Johnson Services Inc
• Mallinckrodt Plc
• Gelita GmbH
• Z-Medica LLC.

The key players of pre-filled hemostasis agents follow the strategy of mergers, acquisitions and R&D investments and tie-ups with hospitals.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13374

Pre-filled Hemostasis Agents market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.

Key Segments

By Type: 

• Sealants
  • Fibrin sealants
  • Synthetic sealants
• Hemostats
  • Mechanical
    • Collagen
    • Oxidized regenerated cellulose
    • Gelatin
  • Active
  • Flowable
• Adhesives
  • Albumin and glutaraldehyde
  • Cyanoacrylate

By Treatment: 

• Obstetrics
• Cardiovascular
• Neurosurgery
• Digestive Surgery
• General Surgery
• Others

By End User: 

• Hospitals
• Surgical Centers
• Others

By Region: 

• North America
  • US
  • Canada
• Latin America
  • Brazil
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • BENELUX
  • Russia
• South Asia
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Rest of South Asia
• East Asia
• China
• Japan
• South Korea
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Turkey

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13374

[195 Pages Report]  With deployment of advanced technologies, medical practitioners will keep adopting specialised devices that facilitate specific surgical operations in medical procedures. Rising number of invasive surgeries has necessitated the need for improved devices for wound management. And, surgical staples have effectively replaced sutures for closing wounds during such procedures.

Future Market Insights recently published its report on the global market for surgical stapling devices, the highlights from which indicate that rising number of laparoscopic surgeries performed across the globe have triggered the use of surgical stapling devices.

According to Future Market Insights, the global demand for surgical stapling devices is propelling along with the world’s rising geriatric population. Lesser time consumed by surgical stapling devices for closing wounds, and the accuracy & precision of these devices is favouring their adoption for treating wounds of aged patients. In 2016, close to US$ 2,000 Mn worth of surgical stapling devices were sold in the world. The report projects that these revenues will be doubled by the end of 2026, projecting that the global surgical stapling devices market will soar steadily at 7.6% CAGR.

In the report, titled “Surgical Stapling Devices Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” North America has been identified as the largest market for surgical stapling devices. By the end of forecast period, more than US$ 1,000 Mn revenues will be solely attributed by North America’s surgical stapling devices market.

Advanced healthcare infrastructure in Western Europe has facilitated the region’s surgical stapling devices market, which will register a value CAGR of 7.9% through 2026. Although, fastest consumption of surgical stapling devices will be witnessed in the Asia-Pacific excluding Japan (APEJ) region. The APEJ surgical stapling devices market is expected to soar at the highest CAGR of 8.6%. 

Leading Manufacturers of Surgical Stapling Devices: Medtronic plc, Grena Ltd., Purple Surgical Holdings Limited, Dextera Surgical Inc., Johnson & Johnson Services, Inc., 3M Company, and Meril Life Sciences Pvt. Ltd.

The report reveals that hospitals will remain the largest end-users of surgical stapling devices in the world – accounting for more than 60% of global revenues. Meanwhile, the demand for surgical stapling devices will also gain traction in ambulatory surgical centres. Key findings in the report indicate that powered surgical stapling devices worth US$ 1,182 Mn were sold globally in 2016, while the demand for manual surgical stapling products is anticipated to incur a downtrend in the years to come.

Throughout the forecast period, six out of ten surgical stapling devices sold in the world are likely to be disposable, while revenues from reusable surgical stapling products will be growing at a sluggish rate. Preference to curved surgical stapling is also on a rise, revenues from which are expected to soar impressively at 9% CAGR.

Request a Sample Report with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-867

Dermatological surgeries will undoubtedly require greater number of surgical stapling devices. The report estimates that in 2016, nearly US$ 600 million revenues were amassed from the sales of surgical stapling devices in treatment of skin-related surgical wounds. The use of advanced surgical stapling devices is also expected to gain momentum for closing dissected or ruptured blood vessels during surgeries. Wounds situated in the patient’s digestive tract are also being treated by surgical stapling, and by the end of 2026, around US$ 665 million worth of devices will be consumed for such treatments.

We have segmented the global surgical stapling devices market into six sections. They are as follows:By Region 

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• Japan
• MEA

By End User

• Hospitals
• Ambulatory Surgical Centres
• Others

By Stapling Type

• Straight
• Curved
• Circular

By Usage Type

• Disposable Surgical Stapling Devices
• Reusable Surgical Stapling Devices

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-867

By Indication

• Skin
• Digestive Tract
• Blood Vessels
• Hernia
• Lungs
• Others

By Product

• Powered Surgical Stapling Devices
• Manual Surgical Stapling Devices

[183 Pages Report] Applications of microfluidics in drug delivery and diagnostics will continue to fuel the market for microfluidics over the next few years. “The US$ 2.9 Bn microfluidics market will possibly cross US$ 11 Bn by the end of 2026. North America is expected to contribute over US$ 3 Bn to the total revenues in 2026. The collective share of North America and Asia Pacific will be over 40%,” states Future Market Insights in a recently published market report outlook, titled “Microfluidics Market: Global Industry Analysis and Opportunity Assessment, 2016-2026.”

he report by Future Market Insights analyses the global market for microfluidics over a 10-year forecast period, 2016-2026. The market is likely to witness a robust CAGR of 14.4% over the assessed period.

Key Insights: Market Dynamics

• Increasing discretionary funding from national labs for R&D in the developed regions will remain a primary factor driving the growth of market through 2026.
• Improving healthcare infrastructure and wide availability of affordable microfluidic devices or kits are also foreseen to boost the market growth in near future, especially in developing countries.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-398

• Expansion of drug delivery sector will favour the market growth in near future.
• Consistent advancements in the fields of genomics and proteomics are also expected to benefit the sales of microfluidics-based devices and kits.
• Dynamic collaborations between key market players and active involvement of government entities will collectively foster the market through 2026.

Key Insights: Segments

Ceramics will remain dominant material type

Based on material, ceramics will continue to be the most sought after material for microfluidic device or kit manufacturing. Ceramics segment is expected to remain dominance, accounting for over 42% market value share in 2026, followed by glass, polymer, and silicon. While ceramics is likely to witness the fastest growth, polymer segment is anticipated to exhibit a significant CAGR of over 15% over 2016-2026, driven by PVC.

POCT will be dominant application segment

By application, POCT (point of care testing) segment is projected to retain dominance through 2026, accounting for over 33% share in terms of revenues. Clinical diagnostics and analytical testing will remain the next major segments in the global microfluidics market.

In-vitro diagnostics industry will hold maximum revenue share

On the basis of industry, in-vitro diagnostics, life science research, and pharmaceuticals are likely to be the key segments. In-vitro diagnostics segment is estimated to hold a share of over 35% in the total market revenues. The fastest growing segment will be in-vitro diagnosis.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-398

APEJ will be the most lucrative regional market

Geographically, North America, followed by Western Europe are expected to remain the dominant regions for microfluidics, capturing respective market value share of over 26% and over 21% share by 2026 end. Asia Pacific (excluding Japan) will possibly represent the most lucrative market, expanding at a significant CAGR of over 14% throughout the forecast period. This growth is attributed to growing use of microfluidics devices and kits for in-vitro diagnostics. North America and Western Europe will also exhibit significant growth rates over 2016-2026.

Key Insights: Leading Market Players

Some of the most prominent players in the global microfluidics market, include Agilent Technologies, PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen NV, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Abbott Laboratories, and F. Hoffmann-La Roche Ltd.

Almost all the leading companies serve point of care testing application and survive the competition with an individual differentiating strategy. Thermo Fisher Scientific Inc. and Abbott Laboratories, through active engagement in agreements and collaborations with leading regional companies, highlight a growing trend of strategic mergers and acquisitions among the top companies.

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-398